A Meta-Analysis: Correlation between Hypertension of Comorbidity on Mortality in Patients with COVID-19

Nanda Agustian Simatupang, V. Widyaningsih, S. Sumardiyono
{"title":"A Meta-Analysis: Correlation between Hypertension of Comorbidity on Mortality in Patients with COVID-19","authors":"Nanda Agustian Simatupang, V. Widyaningsih, S. Sumardiyono","doi":"10.26911/jepublichealth.2021.06.01.07","DOIUrl":null,"url":null,"abstract":"Background: SARS-CoV-2 is a new type of coronavirus that has never been previously identified in humans. In severe cases of COVID-19 it can cause pneumonia, acute respiratory syndrome, kidney failure, and even death. Hypertension causes a number of patho­physiological changes in the cardiovascular system such as left ventricular hypertrophy and fibrosis. This can make a hypertensive heart particularly vulnerable to SARS-CoV-2. This study aims to analyze and estimate the effect of comorbid hypertension on mortality in COVID-19 patients. Subjects and Method: This was a systematic review and meta-analysis conducted with PRISMA flow diagram. Article searches through journal databases include: Google Scholar, PubMed, Science Direct, and Springer Link by selecting articles published in 2020 and 2021. The keywords used are “Hypertension” OR “Hypertensive Patient” OR “Blood Pres­sure”, “Systolic Pressure” OR “Diastolic Pres­sure” AND “Mortality”, OR “death” OR “loss” AND “COVID-19” OR “SARS-COV-2” OR “coro­navirus” AND “multivariate”. The inclusion criteria were full paper articles with observa­tional research methods, the results of the analysis used the aOR value, the exposure given was comorbid hypertension, the research sub­jects were COVID-19 patients, with mortality outcomes. Eligible articles were analyzed using the Revman 5.3 app. Results: A meta-analysis of 18 articles showed that confirmed COVID-19 patients who had comorbid hypertension had a 1.27 times risk of mortality compared to those without comorbid hypertension and were statistically significant (aOR= 1.27; 95% CI= 1.14 to 1.41; p <0.001). Conclusion: Comorbid Hypertension affects the mortality of COVID-19 patients. Keywords: hypertension, mortality, COVID-19, meta-analysis Correspondence:  Nanda Agustian Simatupang. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: nandaagustian9@gmail.com. Mobile: 082247604322. Journal of Epidemiology and Public Health (2021), 06(01) https://doi.org/10.26911­/jepublic­health.2021.06.01.07","PeriodicalId":91740,"journal":{"name":"Journal of epidemiology and public health reviews","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of epidemiology and public health reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26911/jepublichealth.2021.06.01.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: SARS-CoV-2 is a new type of coronavirus that has never been previously identified in humans. In severe cases of COVID-19 it can cause pneumonia, acute respiratory syndrome, kidney failure, and even death. Hypertension causes a number of patho­physiological changes in the cardiovascular system such as left ventricular hypertrophy and fibrosis. This can make a hypertensive heart particularly vulnerable to SARS-CoV-2. This study aims to analyze and estimate the effect of comorbid hypertension on mortality in COVID-19 patients. Subjects and Method: This was a systematic review and meta-analysis conducted with PRISMA flow diagram. Article searches through journal databases include: Google Scholar, PubMed, Science Direct, and Springer Link by selecting articles published in 2020 and 2021. The keywords used are “Hypertension” OR “Hypertensive Patient” OR “Blood Pres­sure”, “Systolic Pressure” OR “Diastolic Pres­sure” AND “Mortality”, OR “death” OR “loss” AND “COVID-19” OR “SARS-COV-2” OR “coro­navirus” AND “multivariate”. The inclusion criteria were full paper articles with observa­tional research methods, the results of the analysis used the aOR value, the exposure given was comorbid hypertension, the research sub­jects were COVID-19 patients, with mortality outcomes. Eligible articles were analyzed using the Revman 5.3 app. Results: A meta-analysis of 18 articles showed that confirmed COVID-19 patients who had comorbid hypertension had a 1.27 times risk of mortality compared to those without comorbid hypertension and were statistically significant (aOR= 1.27; 95% CI= 1.14 to 1.41; p <0.001). Conclusion: Comorbid Hypertension affects the mortality of COVID-19 patients. Keywords: hypertension, mortality, COVID-19, meta-analysis Correspondence:  Nanda Agustian Simatupang. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: nandaagustian9@gmail.com. Mobile: 082247604322. Journal of Epidemiology and Public Health (2021), 06(01) https://doi.org/10.26911­/jepublic­health.2021.06.01.07
一项荟萃分析:高血压合并症与COVID-19患者死亡率的相关性
背景:SARS-CoV-2是一种以前从未在人类中发现的新型冠状病毒。在COVID-19严重病例中,它可导致肺炎、急性呼吸综合征、肾衰竭甚至死亡。高血压引起许多心血管系统的病理生理变化,如左心室肥厚和纤维化。这可能使高血压心脏特别容易受到SARS-CoV-2的影响。本研究旨在分析和评估合并高血压对COVID-19患者死亡率的影响。对象和方法:本研究采用PRISMA流程图进行系统综述和荟萃分析。通过期刊数据库检索文章包括:Google Scholar、PubMed、Science Direct和Springer Link,选择发表于2020年和2021年的文章。使用的关键词是“高血压”或“高血压患者”或“血压”,“收缩压”或“舒张压”和“死亡率”,或“死亡”或“损失”和“COVID-19”或“SARS-COV-2”或“冠状病毒”和“多变量”。纳入标准为论文全文,采用观察性研究方法,分析结果采用aOR值,给予暴露为合并症高血压,研究对象为COVID-19患者,死亡结局。使用Revman 5.3应用程序对符合条件的文章进行分析。结果:对18篇文章的荟萃分析显示,合并高血压的确诊COVID-19患者的死亡风险是未合并高血压患者的1.27倍,差异有统计学意义(aOR= 1.27;95% CI= 1.14 ~ 1.41;p < 0.001)。结论:高血压合并症影响COVID-19患者的死亡率。关键词:高血压,死亡率,COVID-19, meta分析对应:Nanda Agustian Simatupang。塞贝拉斯市场大学公共卫生硕士课程。杰。红外光谱。Sutami 36A, Surakarta 57126,中爪哇。电子邮件:nandaagustian9@gmail.com。手机:082247604322。流行病学和公共卫生杂志(2021),06(01)https://doi.org/10.26911 - / jepublic-health.2021.06.01.07
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信